- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06217991
A Clinical Study of Laparoscopic Proximal Gastrectomy Based on PTST(Parachute-tunnel- Style Technique) Esophagogastric Anastomose.
January 11, 2024 updated by: Tang-Du Hospital
A Single-center, Prospective, Single-arm Clinical Study of Laparoscopic Proximal Gastrectomy Based on an Original Esophagogastric Anastomose (PTST,Parachute- Tunnel- Style Technique)
- To evaluate the safety, simplicity and effectiveness of the gastric function (anti-reflux) preservation of the innovative "parachute-tunnel-style technique" (PTST) in laparoscopic proximal gastrectomy.
- To investigate the correlation between anastomotic stenosis and blood supply of serosa-muscle flap,suture after esophagogastric anastomosis.(obtain objective indexes such as blood supply, healing pattern and length change of serosa-muscle flap through animal experiments)
Study Overview
Status
Enrolling by invitation
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Shannxi Province
-
Xi'an, Shannxi Province, China
- General Surgery Gastrointestinal Department,Tang-Du of Fourth Military Medical University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Gastric cancer was confirmed histopathologically;
- Patients who may undergo proximal gastrectomy according to guidelines;
- Early upper gastric cancer, more than 1/2 of the distal gastric remnant remained after resection;
- Esophagogastric junction carcinoma with maximum diameter ≤4 cm;
- Patients with advanced upper gastric cancer (MSI-H) achieved cCR by neoadjuvant immunochemotherapy.
Exclusion Criteria:
- Patients with systemic conditions that cannot tolerate laparoscopic surgery;
- Distal gastric remnant was less than 1/2 after proximal gastrectomy.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: PTST anastomose group after proximal gastrectomy
Standard procedure: Patient placed in a supine position and proximal gastrectomy performed under general anesthesia.
|
Suture the gastric remnant at the mark on the back wall of the esophagus.(Don't
tighten the suture); Pull the esophageal stump out of the tunnel meanwhile tighten the suture and the gastric stump to close the back wall of the esophagus and the gastric stump together;Cut the back esophageal wall close to the esophageal stump,cut the front gastric wall along line B. Suture the back esophageal wall and the upper edge of the front gastric wall incision from right to left;Remove residual esophageal nail, and suture the back esophageal wall and the lower edge of the gastric incision from right to left.
Suture the anterior wall of the stomach at the lower edge of the tunnel with the serosa layer at the lower edge of the front wall of the esophagus stomach anastomosis;Suture the upper edge of the tunnel with the front wall of the esophagus and the left and right lateral walls at the gastric stump suture of the original posterior wall of the esophagus.
(all use 3-0 barbed suture continuously)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
occurrence rate of anastomotic stenosis
Time Frame: one month after surgery
|
morbidity(%)
|
one month after surgery
|
|
occurrence rate of reflux esophagitis
Time Frame: three month after surgery; six month after surgery
|
|
three month after surgery; six month after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2023
Primary Completion (Estimated)
June 30, 2025
Study Completion (Estimated)
December 30, 2025
Study Registration Dates
First Submitted
December 17, 2023
First Submitted That Met QC Criteria
January 11, 2024
First Posted (Estimated)
January 23, 2024
Study Record Updates
Last Update Posted (Estimated)
January 23, 2024
Last Update Submitted That Met QC Criteria
January 11, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- XKT-Y-20221148
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gastroesophageal-junction Cancer
-
xiaohua liNot yet recruitingGastroesophageal Junction Cancer
-
Rigshospitalet, DenmarkDanish Cancer SocietyCompletedGastroesophageal-junction CancerDenmark
-
Jiangsu Alphamab Biopharmaceuticals Co., LtdCompletedGastric/Gastroesophageal Junction CancerChina
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); PfizerRecruitingAdvanced Malignant Solid Neoplasm | Metastatic Colorectal Adenocarcinoma | Metastatic Gastroesophageal Junction Adenocarcinoma | Stage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Clinical Stage III... and other conditionsUnited States
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.Active, not recruitingGastric or Gastroesophageal Junction CancerChina
-
Charite University, Berlin, GermanyNot yet recruitingGastric and Gastroesophageal Junction CancerGermany
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)RecruitingClinical Stage III Gastric Cancer AJCC v8 | Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Clinical Stage IV Gastric Cancer AJCC v8 | Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 | Metastatic Gastric Adenocarcinoma | Metastatic Gastroesophageal Junction... and other conditionsUnited States
-
Changchun GeneScience Pharmaceutical Co., Ltd.The First Affiliated Hospital with Nanjing Medical University; Fujian Cancer... and other collaboratorsCompletedAdvanced Gastric or Gastroesophageal Junction CancerChina
-
M.D. Anderson Cancer CenterRecruitingClinical Stage III Gastric Cancer AJCC v8 | Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Clinical Stage IV Gastric Cancer AJCC v8 | Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 | Metastatic Gastric Adenocarcinoma | Metastatic Gastroesophageal Junction... and other conditionsUnited States
-
Zhejiang Cancer HospitalRecruitingMetastatic HER2 Positive Gastroesophageal Junction CancerChina
Clinical Trials on PTST(parachute-tunnel-style technique)for esophagogastrostomy
-
Medical University of WarsawUnknown
-
Medical University of SilesiaCompletedGingival RecessionPoland
-
RenJi HospitalRecruitingPatent Oval ForamenChina
-
Medical University of WarsawCompleted
-
University of Sao PauloWithdrawnGingival Recession | Gingival Recession, Generalized | Xenograft ModelBrazil
-
Misr University for Science and TechnologyCompletedCarpal Tunnel SyndromeEgypt
-
Medical University of WarsawRecruiting
-
Sohag UniversityRecruitingPoly Cystic Ovary Treatment for InfertilityEgypt